| Gerald J Hansen Iv, DO | |
|
721 Arbor Way Ste 105, Blue Bell, PA 19422-1974 | |
| (215) 646-9220 | |
| (215) 646-0715 |
| Full Name | Gerald J Hansen Iv |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 721 Arbor Way Ste 105, Blue Bell, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467987743 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS020320 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Health Home Care And Hospice | Willow grove, PA | Home health agency |
| Mercy Home Health | Springfield, PA | Home health agency |
| Abington Memorial Hospital | Abington, PA | Hospital |
| Willowbrooke Court-spring Hous | Lower gwynedd, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abington Memorial Hospital | 3274437736 | 528 |
| Novacare Outpatient Rehabilitation East Inc | 3678480290 | 617 |
News Archive
eHealthInsurance (NASDAQ: EHTH) today released a list of answers to questions frequently asked from people concerned about the H1N1 virus (also called swine flu) and their health insurance, who have called into its Customer Care Center, which includes a call center staffed with licensed insurance agents. Getting answers to these questions is particularly important for high-risk individuals: pregnant women, children and seniors.
A recent study by researchers from Sweden and the United Kingdom shows that CRISPR/Cas9-based genomic engineering can prompt unwanted on-target effects, and highlights the complexity of human DNA repair mechanisms in the presence of the powerful prokaryotic Cas9 nuclease. The paper is currently available on the bioRxiv* preprint server.
Drugs that can stop or reverse Alzheimer's disease progression are not available yet, but a number of potentially promising clinical trials could hold the key for modifying the treatment of the disease.
Incept BioSystems, Inc., a privately-held biomedical device company using patented microfluidic technology developed at the University of Michigan, announced today that it has initiated the first U.S. human clinical trial of its proprietary SMART Embryo Culture System. The microscale SMART technology platform is designed to improve the in vitro manipulation, performance, and viability of embryos for the treatment of patients undergoing in vitro fertilization (IVF).
› Verified 5 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235286253 PECOS PAC ID: 3274437736 Enrollment ID: O20040325000619 |
News Archive
eHealthInsurance (NASDAQ: EHTH) today released a list of answers to questions frequently asked from people concerned about the H1N1 virus (also called swine flu) and their health insurance, who have called into its Customer Care Center, which includes a call center staffed with licensed insurance agents. Getting answers to these questions is particularly important for high-risk individuals: pregnant women, children and seniors.
A recent study by researchers from Sweden and the United Kingdom shows that CRISPR/Cas9-based genomic engineering can prompt unwanted on-target effects, and highlights the complexity of human DNA repair mechanisms in the presence of the powerful prokaryotic Cas9 nuclease. The paper is currently available on the bioRxiv* preprint server.
Drugs that can stop or reverse Alzheimer's disease progression are not available yet, but a number of potentially promising clinical trials could hold the key for modifying the treatment of the disease.
Incept BioSystems, Inc., a privately-held biomedical device company using patented microfluidic technology developed at the University of Michigan, announced today that it has initiated the first U.S. human clinical trial of its proprietary SMART Embryo Culture System. The microscale SMART technology platform is designed to improve the in vitro manipulation, performance, and viability of embryos for the treatment of patients undergoing in vitro fertilization (IVF).
› Verified 5 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588819593 PECOS PAC ID: 3274437736 Enrollment ID: O20090131000010 |
News Archive
eHealthInsurance (NASDAQ: EHTH) today released a list of answers to questions frequently asked from people concerned about the H1N1 virus (also called swine flu) and their health insurance, who have called into its Customer Care Center, which includes a call center staffed with licensed insurance agents. Getting answers to these questions is particularly important for high-risk individuals: pregnant women, children and seniors.
A recent study by researchers from Sweden and the United Kingdom shows that CRISPR/Cas9-based genomic engineering can prompt unwanted on-target effects, and highlights the complexity of human DNA repair mechanisms in the presence of the powerful prokaryotic Cas9 nuclease. The paper is currently available on the bioRxiv* preprint server.
Drugs that can stop or reverse Alzheimer's disease progression are not available yet, but a number of potentially promising clinical trials could hold the key for modifying the treatment of the disease.
Incept BioSystems, Inc., a privately-held biomedical device company using patented microfluidic technology developed at the University of Michigan, announced today that it has initiated the first U.S. human clinical trial of its proprietary SMART Embryo Culture System. The microscale SMART technology platform is designed to improve the in vitro manipulation, performance, and viability of embryos for the treatment of patients undergoing in vitro fertilization (IVF).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gerald J Hansen Iv, DO 2500 Maryland Rd Ste 400, Willow Grove, PA 19090-1225 Ph: (215) 481-4143 | Gerald J Hansen Iv, DO 721 Arbor Way Ste 105, Blue Bell, PA 19422-1974 Ph: (215) 646-9220 |
News Archive
eHealthInsurance (NASDAQ: EHTH) today released a list of answers to questions frequently asked from people concerned about the H1N1 virus (also called swine flu) and their health insurance, who have called into its Customer Care Center, which includes a call center staffed with licensed insurance agents. Getting answers to these questions is particularly important for high-risk individuals: pregnant women, children and seniors.
A recent study by researchers from Sweden and the United Kingdom shows that CRISPR/Cas9-based genomic engineering can prompt unwanted on-target effects, and highlights the complexity of human DNA repair mechanisms in the presence of the powerful prokaryotic Cas9 nuclease. The paper is currently available on the bioRxiv* preprint server.
Drugs that can stop or reverse Alzheimer's disease progression are not available yet, but a number of potentially promising clinical trials could hold the key for modifying the treatment of the disease.
Incept BioSystems, Inc., a privately-held biomedical device company using patented microfluidic technology developed at the University of Michigan, announced today that it has initiated the first U.S. human clinical trial of its proprietary SMART Embryo Culture System. The microscale SMART technology platform is designed to improve the in vitro manipulation, performance, and viability of embryos for the treatment of patients undergoing in vitro fertilization (IVF).
› Verified 5 days ago
Dr. Debra Vermette, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1787 Sentry Pkwy W Bldg 16, Suite 400, Blue Bell, PA 19422 Phone: 215-542-3000 Fax: 215-542-3070 | |
Dr. George David Vermeire, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 930 Harvest Dr, Ms Ub1n, Blue Bell, PA 19422 Phone: 215-775-5123 Fax: 215-775-5140 | |
Michele Metree Meredith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 721 Skippack Pike Ste 3, Blue Bell, PA 19422 Phone: 484-622-6700 | |
Dr. Jennifer Anne Lorine, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 725 Skippack Pike, Blue Bell, PA 19422 Phone: 610-613-5042 | |
Dr. William Callahan, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 721 Arbor Way Ste 105, Blue Bell, PA 19422 Phone: 215-646-9220 Fax: 215-646-0715 | |
David C. Peet Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 721 Skippack Pike, Suite 3, Blue Bell, PA 19422 Phone: 215-793-0600 Fax: 215-793-0759 | |
Dr. Nancy S Czarnecki, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 920b Harvest Dr, 1st Floor, Blue Bell, PA 19422 Phone: 215-775-5435 Fax: 215-775-5440 |